November 15, 2014

Cost Effectiveness of Current HIV Cure Approaches

Published: November 14, 2014 DOI: 10.1371/journal.pone.0113031 Abstract Background We examined efficacy, toxicity, relapse, cost, and quality-of-life thresholds of hypothetical HIV cure interventions that would make them […]
November 15, 2014

Groundbreaking HIV vaccine’s effects were real – and could be made to work better

Findings from further studies using a reformulation of the only HIV vaccine that has ever worked in a large efficacy trial were presented at the recent HIV […]
November 15, 2014

Prevalence and risk factors of sleep disturbances in a large HIV-infected adult population.

Prevalence and risk factors of sleep disturbances in a large HIV-infected adult population. Authors Allavena C1, Guimard T2, Billaud E3, de la Tullaye S4, Reliquet V1, Pineau S3, Hüe H3, Supiot C1,Chennebault JM5, Michau […]
October 22, 2014

Ibalizumab: First HIV Drug to Get Orphan Drug Status for Salvage Patients

Shares of TaiMed Biologics Inc, which manufactures drugs to treat AIDS, soared 12.93 percent yesterday after its new TMB-355 drug for intravenous injection was granted orphan […]